Master10
General Science20 Concepts & Facts

RNA Splicing (Introns, Exons & Spliceosome) GK Facts, Overview & Study Guide

Reviewed by the Master10 Editorial Board for accuracy, clarity and competitive-exam relevance.Editorial Policy
RNA splicing represents a fundamental eukaryotic post-transcriptional modification taking place inside the cell nucleus prior to cytoplasmic translation. Following gene transcription by RNA polymerase II, newly synthesized precursor messenger RNA, designated as pre-mRNA or heterogeneous nuclear RNA, contains both coding sequences termed exons and intervening non-coding regions termed introns. Through coordinated biochemical cleavage and ligation, RNA splicing excises non-functional introns while conjoining exons into continuous coding transcripts. This nuclear event proceeds synchronously with two other major RNA modifications: five-prime 7-methylguanosine capping and three-prime polyadenylation. Splicing fidelity is guided by the spliceosome, a massive multi-megadalton ribonucleoprotein apparatus that recognizes invariant splice-site consensus motifs located at intron boundaries to safeguard translational reading frames.

The breakthrough discovery of split genes occurred in 1977, when American molecular biologists Richard J. Roberts and Phillip A. Sharp independently identified looping structures in adenovirus hybridizations, earning the 1993 Nobel Prize in Physiology or Medicine. Geneticist Walter Gilbert coined the terms intron and exon in 1978. Chemically, splicing occurs through two successive transesterification reactions without requiring external high-energy nucleoside triphosphates. Five small nuclear RNAs, designated U1, U2, U4, U5, and U6, associate with specialized polypeptide complexes to form small nuclear ribonucleoproteins, colloquially known as snurps. These molecular machines recognize the Breathnach–Chambon rule, which dictates an invariant GU dinucleotide at the five-prime donor site and an AG dinucleotide at the three-prime acceptor site, looping the excised intron into a characteristic lariat structure.

Alternative splicing provides an extraordinary evolutionary advantage by allowing approximately twenty thousand human protein-coding genes to generate over one hundred thousand distinct functional protein isoforms. Differential exon inclusion, exclusion, or alternative splice site selection dynamically expands proteomic diversity across various anatomical tissues. Aberrant splicing patterns trigger multiple human genetic disorders, including beta-thalassemia, cystic fibrosis, and spinal muscular atrophy. Modern therapeutic advances exploit antisense oligonucleotides, exemplified by nusinersen, to correct exon skipping in spinal muscular atrophy patients. In competitive examinations, mastering RNA processing mechanics, identifying catalytic small nuclear ribonucleoproteins, analyzing intron conservation rules, and evaluating the distinction between self-splicing ribozymes and spliceosomal activity are high-frequency assessment areas within general science, molecular genetics, and medical pharmacology curricula.

Key Concepts & Self-Assessment20 Key Facts

Review key RNA Splicing (Introns, Exons & Spliceosome) exam facts and rate your mastery to track revision.

Progress: 0/20 Rated 0 Mastered 0 Review Later
#1
RNA splicing represents the nuclear post-transcriptional process wherein non-coding introns are excised from precursor messenger RNA while coding exons are ligated together.
#2
Eukaryotic gene maturation involves three concurrent co-transcriptional modifications: 5-prime 7-methylguanosine capping, intervening sequence splicing, and 3-prime polyadenylation with a poly-A tail.
#3
Richard J. Roberts and Phillip A. Sharp discovered split eukaryotic genes in 1977, subsequently receiving the 1993 Nobel Prize in Physiology or Medicine.
#4
Evolutionary biologist Walter Gilbert coined the descriptive terms introns for intervening non-coding regions and exons for expressed protein-coding sequences in 1978.
#5
The major spliceosome is an intricate multi-megadalton ribonucleoprotein complex comprising five small nuclear RNAs: U1, U2, U4, U5, and U6 snRNAs.
#6
Small nuclear ribonucleoproteins, abbreviated as snRNPs or snurps, assemble dynamically upon pre-mRNA substrates to execute sequence recognition and catalytic transesterification.
#7
Splicing obeys the Breathnach–Chambon rule, which specifies invariant GU dinucleotides at 5-prime splice donor sites and AG dinucleotides at 3-prime acceptor sites.
#8
The branch point sequence contains an invariant adenine nucleotide whose 2-prime hydroxyl group initiates nucleophilic attack on the 5-prime splice donor phosphate.
#9
The first transesterification cleavage creates an atypical 2-prime to 5-prime phosphodiester bond, liberating exon one and folding the intron into a lariat.
#10
The second transesterification reaction occurs when the 3-prime hydroxyl of exon one attacks the 3-prime splice junction, ligating exons and releasing the lariat.
#11
Excised intron lariats undergo rapid enzymatic debranching by RNA lariat debranching enzyme before undergoing degradation by nuclear exoribonucleases into individual mononucleotides.
#12
Thomas Cech earned the 1989 Nobel Prize in Chemistry for discovering Group I self-splicing catalytic ribozyme introns in the ciliate protozoan Tetrahymena thermophila.
#13
Alternative splicing enables twenty thousand human genes to generate over one hundred thousand distinct proteins through selective exon inclusion, exclusion, or site shifting.
#14
Exon skipping, mutually exclusive exons, and alternative donor or acceptor site usage represent major mechanisms generating functional tissue-specific protein diversity.
#15
Mutations disrupting splicing consensus sequences cause approximately fifteen percent of all point-mutation genetic diseases, including variants of beta-thalassemia and cystic fibrosis.
#16
Spinal muscular atrophy results from mutations in the SMN1 gene, leaving patients reliant on the poorly spliced paralogous survival motor neuron gene SMN2.
#17
The antisense drug nusinersen binds pre-mRNA to modify SMN2 splicing, promoting inclusion of exon 7 and restoring functional survival motor neuron protein synthesis.
#18
The minor or U12-type spliceosome processes rare non-canonical introns containing AU-AC terminal dinucleotides, utilizing specialized U11, U12, U4atac, and U6atac snRNAs.
#19
Unlike eukaryotes, prokaryotic organisms generally lack spliceosomal introns, allowing simultaneous coupled transcription and translation along their polycistronic bacterial genomic transcripts.
#20
Exon junction complexes deposit on mature messenger RNA twenty nucleotides upstream of spliced junctions, guiding cytoplasmic mRNA export and nonsense-mediated decay surveillance.

Subject Specialist Commentary

Analytical perspective & practical exam advice from the Master10 academic board

Educator's Insight
Think of RNA splicing as film editing in cinematography. The camera captures extended raw footage containing awkward pauses, bloopers, and technical calibrations alongside dramatic acting scenes. The film editor carefully trims away the dead footage—the non-coding introns—and glues together the compelling acting segments—the exons—into a seamless cinematic release. Splicing ensures that only coherent narrative sequences reach the cytoplasmic audience for productive translation into functional biological characters.
A common examination trap confuses intron splicing with RNA interference or DNA recombination; splicing alters pre-mRNA without modifying chromosomal DNA or degrading transcripts. Remember the acronym SPLIT: Spliceosome complexes, Phosphodiester transesterifications, Lariat formation, Invariant GU-AG junctions, and Translated exon maturation. Recalling that the branch site adenine initiates the first transesterification attack will prevent confusing chemical cleavage and ligation mechanisms during demanding competitive national molecular biology examinations.

Related Knowledge Topics to Discover

Looking for more GK practice?

Explore 52,789+ questions across 65 General Knowledge categories.

Open Interactive Search